Kenneth Lee Byron - Publications

Loyola University Chicago, Chicago, IL, United States 

57 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Brueggemann LI, Cribbs LL, Byron KL. Heteromeric Channels Formed From Alternating Kv7.4 and Kv7.5 α-Subunits Display Biophysical, Regulatory, and Pharmacological Characteristics of Smooth Muscle M-Currents. Frontiers in Physiology. 11: 992. PMID 32903335 DOI: 10.3389/Fphys.2020.00992  0.519
2020 Brueggemann LI, Cribbs LL, Byron KL. Structural Determinants of Kv7.5 Potassium Channels That Confer Changes in Phosphatidylinositol 4,5-Bisphosphate (PIP) Affinity and Signaling Sensitivities in Smooth Muscle Cells. Molecular Pharmacology. 97: 145-158. PMID 31871302 DOI: 10.1124/Mol.119.117192  0.607
2020 Byron KL, Brueggemann LI, Sandhu G, Cabe M, Cribbs LL. A link between the inflammatory mediator interleukin‐13, the transcriptional repressor REST, the KCNQ5 gene, and Kv7.5 potassium channel function in vascular smooth muscle cells The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05984  0.498
2018 Brueggemann LI, Cribbs LL, Schwartz J, Wang M, Kouta A, Byron KL. Mechanisms of PKA-Dependent Potentiation of Kv7.5 Channel Activity in Human Airway Smooth Muscle Cells. International Journal of Molecular Sciences. 19. PMID 30061510 DOI: 10.3390/Ijms19082223  0.553
2018 Nassoiy SP, Babu FS, LaPorte HM, Byron KL, Majetschak M. Effects of the Kv7 voltage-activated potassium channel inhibitor linopirdine in rat models of hemorrhagic shock. Clinical and Experimental Pharmacology & Physiology. PMID 29702725 DOI: 10.1111/1440-1681.12958  0.373
2018 Byron KL, Brueggemann LI. Kv7 potassium channels as signal transduction intermediates in the control of microvascular tone. Microcirculation (New York, N.Y. : 1994). 25. PMID 28976052 DOI: 10.1111/Micc.12419  0.574
2018 Brueggemann LI, Cribbs LL, Byron KL. Chimeric Kv7.4 Channel with Amino-Terminus of Kv7.5 Has Putative Protein Kinase a Phosphorylation Site and is Sufficient to Confer Partial Sensitivity to Cyclic Adenosine Monophosphate/Protein Kinase a (cAMP/PKA) Pathway Biophysical Journal. 114. DOI: 10.1016/J.Bpj.2017.11.1718  0.404
2017 Haick JM, Brueggemann LI, Cribbs LL, Denning MF, Schwartz J, Byron KL. PKC-DEPENDENT REGULATION OF Kv7.5 CHANNELS BY THE BRONCHOCONSTRICTOR HISTAMINE IN HUMAN AIRWAY SMOOTH MUSCLE CELLS. American Journal of Physiology. Lung Cellular and Molecular Physiology. ajplung.00567.2016. PMID 28283479 DOI: 10.1152/Ajplung.00567.2016  0.627
2017 Nassoiy SP, Byron KL, Majetschak M. Kv7 voltage-activated potassium channel inhibitors reduce fluid resuscitation requirements after hemorrhagic shock in rats. Journal of Biomedical Science. 24: 8. PMID 28095830 DOI: 10.1186/S12929-017-0316-1  0.51
2017 Byron KL, Brueggemann LI, Kouta A, Cribbs LL. Protein Kinase A-Dependent Phosphorylation Modulates the Affinity of Kv7.5 Potassium Channels to Phosphatidylinositol 4,5-Bisphosphate to Enhance Potassium Conductance Biophysical Journal. 112. DOI: 10.1016/J.Bpj.2016.11.1377  0.554
2016 Evans AE, Tripathi A, LaPorte HM, Brueggemann LI, Singh AK, Albee LJ, Byron KL, Tarasova NI, Volkman BF, Cho TY, Gaponenko V, Majetschak M. New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle. International Journal of Molecular Sciences. 17. PMID 27331810 DOI: 10.3390/Ijms17060971  0.34
2016 Haick JM, Byron KL. Novel treatment strategies for smooth muscle disorders: Targeting Kv7 potassium channels. Pharmacology & Therapeutics. PMID 27179745 DOI: 10.1016/J.Pharmthera.2016.05.002  0.557
2015 Mani BK, Robakowski C, Brueggemann LI, Cribbs LL, Tripathi A, Majetschak M, Byron KL. Kv7.5 Potassium Channel Subunits are the Primary Targets for PKA-Dependent Enhancement of Vascular Smooth Muscle Kv7 Currents. Molecular Pharmacology. PMID 26700561 DOI: 10.1016/J.Bpj.2015.11.3242  0.637
2015 Tripathi A, Vana PG, Chavan TS, Brueggemann LI, Byron KL, Tarasova NI, Volkman BF, Gaponenko V, Majetschak M. Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function. Proceedings of the National Academy of Sciences of the United States of America. 112: E1659-68. PMID 25775528 DOI: 10.1073/Pnas.1417564112  0.369
2014 Bach HH, Wong YM, Tripathi A, Nevins AM, Gamelli RL, Volkman BF, Byron KL, Majetschak M. Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function. Molecular Medicine (Cambridge, Mass.). 20: 435-47. PMID 25032954 DOI: 10.2119/Molmed.2014.00101  0.361
2014 Brueggemann LI, Haick JM, Cribbs LL, Byron KL. Differential activation of vascular smooth muscle Kv7.4, Kv7.5, and Kv7.4/7.5 channels by ML213 and ICA-069673 Molecular Pharmacology. 86: 330-341. PMID 24944189 DOI: 10.1124/Mol.114.093799  0.603
2014 Brueggemann LI, Haick JM, Neuburg S, Tate S, Randhawa D, Cribbs LL, Byron KL. KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways. American Journal of Physiology. Lung Cellular and Molecular Physiology. 306: L476-86. PMID 24441871 DOI: 10.1152/Ajplung.00253.2013  0.57
2014 Brueggemann LI, Mackie AR, Cribbs LL, Freda J, Tripathi A, Majetschak M, Byron KL. Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels Journal of Biological Chemistry. 289: 2099-2111. PMID 24297175 DOI: 10.1074/Jbc.M113.527820  0.528
2014 Brueggemann LI, Haick JM, Byron KL. Pharmacological Properties of Homomeric Kv7.4, Kv7.5 and Heteromeric Kv7.4/7.5 Channels: Effects of ICA069673 and Ml213 Biophysical Journal. 106. DOI: 10.1016/J.Bpj.2013.11.829  0.607
2013 Brueggemann LI, Gentile S, Byron KL. Social networking among voltage-activated potassium channels. Progress in Molecular Biology and Translational Science. 117: 269-302. PMID 23663972 DOI: 10.1016/B978-0-12-386931-9.00010-6  0.527
2013 Mani BK, O'Dowd J, Kumar L, Brueggemann LI, Ross M, Byron KL. Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm Journal of Cardiovascular Pharmacology. 61: 51-62. PMID 23107868 DOI: 10.1097/Fjc.0B013E3182771708  0.572
2013 Brueggemann LI, Byron KL. Protein Kinase C-Dependent Modulation of Heterologously Expressed Homomeric Kv7.4, Kv7.5 and Heteromeric Kv7.4/7.5; Differential Sensitivities to Low Concentrations of Vasopressin and PMA in A7R5 Vascular Smooth Muscle Cells Biophysical Journal. 104. DOI: 10.1016/J.Bpj.2012.11.1510  0.616
2012 Brueggemann LI, Mani BK, Haick J, Byron KL. Exploring arterial smooth muscle Kv7 potassium channel function using patch clamp electrophysiology and pressure myography. Journal of Visualized Experiments : Jove. e4263. PMID 23007713 DOI: 10.3791/4263  0.547
2012 Brueggemann LI, Kakad PP, Love RB, Solway J, Dowell ML, Cribbs LL, Byron KL. Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy. American Journal of Physiology. Lung Cellular and Molecular Physiology. 302: L120-32. PMID 21964407 DOI: 10.1152/Ajplung.00194.2011  0.699
2012 Brueggemann LI, Byron KL. Validation of XE991 use as a Selective Irreversible Blocker of Native Kv7 Channels in Smooth Muscle Myocytes Biophysical Journal. 102. DOI: 10.1016/J.Bpj.2011.11.2976  0.553
2011 Mani BK, Brueggemann LI, Cribbs LL, Byron KL. Activation of vascular KCNQ (K v7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery British Journal of Pharmacology. 164: 237-249. PMID 21323904 DOI: 10.1111/J.1476-5381.2011.01273.X  0.481
2011 Mani BK, Byron KL. Vascular KCNQ channels in humans: The sub-threshold brake that regulates vascular tone? British Journal of Pharmacology. 162: 38-41. PMID 21188789 DOI: 10.1111/J.1476-5381.2010.01065.X  0.593
2011 Brueggemann LI, Mackie AR, Martin JL, Cribbs LL, Byron KL. Diclofenac distinguishes among homomeric and heteromeric potassium channels composed of KCNQ4 and KCNQ5 subunits Molecular Pharmacology. 79: 10-23. PMID 20876743 DOI: 10.1124/Mol.110.067496  0.598
2011 Mani BK, Brueggemann LI, Byron KL. Reply to Chadha et al British Journal of Pharmacology. 164: 252-253. DOI: 10.1111/J.1476-5381.2011.01457.X  0.551
2011 Brueggemann LI, Byron KL. Molecular Composition of Functional KCNQ Channels in Vascular Smooth Muscle Cells Based on Effects of Diclofenac Biophysical Journal. 100. DOI: 10.1016/J.Bpj.2010.12.2535  0.602
2010 Brueggemann LI, Mani BK, Mackie AR, Cribbs LL, Byron KL. Novel Actions of Nonsteroidal Anti-Inflammatory Drugs on Vascular Ion Channels: Accounting for Cardiovascular Side Effects and Identifying New Therapeutic Applications. Molecular and Cellular Pharmacology. 2: 15-19. PMID 20689646 DOI: 10.4255/Mcpharmacol.10.03  0.476
2010 Brueggemann LI, Byron KL. Diclofenac Activates Kv7.4 and Inhibits Kv7.5 Potassium Channels Heterologously Expressed in A7r5 Vascular Smooth Muscle Cells Biophysical Journal. 98: 1-3. DOI: 10.1016/J.Bpj.2009.12.668  0.594
2009 Brueggemann LI, Mackie AR, Mani BK, Cribbs LL, Byron KL. Differential effects of selective cyclooxygenase-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles Molecular Pharmacology. 76: 1053-1061. PMID 19605525 DOI: 10.1124/Mol.109.057844  0.457
2009 Byron KL, Brueggemann LI. Labour pains: Giving birth to new mechanisms for the regulation of myometrial contractility Journal of Physiology. 587: 2109-2110. PMID 19443849 DOI: 10.1113/Jphysiol.2009.173641  0.404
2009 Mani BK, Brueggemann LI, Cribbs LL, Byron KL. Opposite regulation of KCNQ5 and TRPC6 channels contributes to vasopressin-stimulated calcium spiking responses in A7r5 vascular smooth muscle cells Cell Calcium. 45: 400-411. PMID 19246091 DOI: 10.1016/J.Ceca.2009.01.004  0.576
2009 Brueggemann LI, Byron KL. Cycloxygenase-2 Inhibitor Celecoxib Is A Potent Activator Of Vascular KCNQ K+ Channels And An Inhibitor Of L-type Ca2+ Channels Biophysical Journal. 96: 1-5. DOI: 10.1016/J.Bpj.2008.12.760  0.575
2008 Mackie AR, Byron KL. Cardiovascular KCNQ (Kv7) potassium channels: Physiological regulators and new targets for therapeutic intervention Molecular Pharmacology. 74: 1171-1179. PMID 18684841 DOI: 10.1124/Mol.108.049825  0.547
2008 Mackie AR, Brueggemann LI, Henderson KK, Shiels AJ, Cribbs LL, Scrogin KE, Byron KL. Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance. The Journal of Pharmacology and Experimental Therapeutics. 325: 475-83. PMID 18272810 DOI: 10.1124/Jpet.107.135764  0.552
2007 Henderson KK, Byron KL. Vasopressin-induced vasoconstriction: Two concentration-dependent signaling pathways Journal of Applied Physiology. 102: 1402-1409. PMID 17204577 DOI: 10.1152/Japplphysiol.00825.2006  0.499
2007 Brueggemann LI, Moran CJ, Barakat JA, Yeh JZ, Cribbs LL, Byron KL. Vasopressin stimulates action potential firing by protein kinase C-dependent inhibition of KCNQ5 in A7r5 rat aortic smooth muscle cells American Journal of Physiology - Heart and Circulatory Physiology. 292. PMID 17071736 DOI: 10.1152/Ajpheart.00065.2006  0.583
2006 Brueggemann LI, Markun DR, Henderson KK, Cribbs LL, Byron KL. Pharmacological and electrophysiological characterization of store-operated currents and capacitative Ca2+ entry in vascular smooth muscle cells Journal of Pharmacology and Experimental Therapeutics. 317: 488-499. PMID 16415091 DOI: 10.1124/Jpet.105.095067  0.567
2005 Brueggemann LI, Markun DR, Barakat JA, Chen H, Byron KL. Evidence against reciprocal regulation of Ca2+ entry by vasopressin in A7r5 rat aortic smooth-muscle cells Biochemical Journal. 388: 237-244. PMID 15603557 DOI: 10.1042/Bj20041360  0.42
2005 Brueggemann LI, Martin BL, Barakat J, Byron KL, Cribbs LL. Low voltage-activated calcium channels in vascular smooth muscle: T-type channels and AVP-stimulated calcium spiking American Journal of Physiology - Heart and Circulatory Physiology. 288. PMID 15498818 DOI: 10.1152/Ajpheart.01126.2003  0.557
2003 Bayer AL, Heidkamp MC, Howes AL, Heller Brown J, Byron KL, Samarel AM. Protein kinase C epsilon-dependent activation of proline-rich tyrosine kinase 2 in neonatal rat ventricular myocytes. Journal of Molecular and Cellular Cardiology. 35: 1121-33. PMID 12967635 DOI: 10.1016/S0022-2828(03)00228-1  0.424
2002 Byron KL, Lucchesi PA. Signal transduction of physiological concentrations of vasopressin in A7r5 vascular smooth muscle cells. A role for PYK2 and tyrosine phosphorylation of K+ channels in the stimulation of Ca2+ spiking. The Journal of Biological Chemistry. 277: 7298-307. PMID 11739373 DOI: 10.1074/Jbc.M104726200  0.483
2001 Li Y, Shiels AJ, Maszak G, Byron KL. Vasopressin-stimulated Ca2+ spiking in vascular smooth muscle cells involves phospholipase D American Journal of Physiology - Heart and Circulatory Physiology. 280: H2658-H2664. PMID 11356622 DOI: 10.1152/Ajpheart.2001.280.6.H2658  0.392
2001 Brueggemann LI, Cribbs LL, Byron KL. The role of T-type Ca2+ channels in vasopressin-stimulated Ca2+ spiking in A7r5 vascular smooth muscle cells Journal of Molecular and Cellular Cardiology. 33. DOI: 10.1016/S0022-2828(01)90063-X  0.496
2000 Fan J, Byron KL. Ca2+ signalling in rat vascular smooth muscle cells: A role for protein kinase C at physiological vasoconstrictor concentrations of vasopressin Journal of Physiology. 524: 821-831. PMID 10790161 DOI: 10.1111/J.1469-7793.2000.00821.X  0.449
2000 Eble DM, Strait JB, Govindarajan G, Lou J, Byron KL, Samarel AM. Endothelin-induced cardiac myocyte hypertrophy: Role for focal adhesion kinase American Journal of Physiology - Heart and Circulatory Physiology. 278. PMID 10775151 DOI: 10.1152/Ajpheart.2000.278.5.H1695  0.35
1998 Sabri A, Govindarajan G, Griffin TM, Byron KL, Samarel AM, Lucchesi PA. Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle. Circulation Research. 83: 841-51. PMID 9776731 DOI: 10.1161/01.Res.83.8.841  0.41
1998 Sabri A, Byron KL, Samarel AM, Bell J, Lucchesi PA. Hydrogen peroxide activates mitogen-activated protein kinases and Na+- H+ exchange in neonatal rat cardiac myocytes Circulation Research. 82: 1053-1062. PMID 9622158 DOI: 10.1161/01.Res.82.10.1053  0.32
1998 Eble DM, Qi M, Waldschmidt S, Lucchesi PA, Byron KL, Samarel AM. Contractile activity is required for sarcomeric assembly in phenylephrine-induced cardiac myocyte hypertrophy American Journal of Physiology - Cell Physiology. 274. PMID 9612209 DOI: 10.1152/Ajpcell.1998.274.5.C1226  0.459
1997 Qi M, Puglisi JL, Byron KL, Ojamaa K, Klein I, Bers DM, Samarel AM. Myosin heavy chain gene expression in neonatal rat heart cells: effects of [Ca2+]i and contractile activity. The American Journal of Physiology. 273: C394-403. PMID 9277337 DOI: 10.1152/Ajpcell.1997.273.2.C394  0.369
1996 Byron KL, Puglisi JL, Holda JR, Eble D, Samarel AM. Myosin heavy chain turnover in cultured neonatal rat heart cells: effects of [Ca2+]i and contractile activity The American Journal of Physiology. 271. PMID 8944626 DOI: 10.1152/Ajpcell.1996.271.5.C01447  0.419
1996 Lucchesi PA, Bell JM, Willis LS, Byron KL, Corson MA, Berk BC. Ca(2+)-dependent mitogen-activated protein kinase activation in spontaneously hypertensive rat vascular smooth muscle defines a hypertensive signal transduction phenotype. Circulation Research. 78: 962-70. PMID 8635246 DOI: 10.1161/01.Res.78.6.962  0.383
1996 Byron KL. Vasopressin Stimulates Ca2+ Spiking Activity in A7r5 Vascular Smooth Muscle Cells via Activation of Phospholipase A2 Circulation Research. 78: 813-820. PMID 8620601 DOI: 10.1161/01.Res.78.5.813  0.429
1995 Byron KL, Taylor CW. Vasopressin stimulation of Ca2+ mobilization, two bivalent cation entry pathways and Ca2+ efflux in A7r5 rat smooth muscle cells Journal of Physiology. 485: 455-468. PMID 7666368 DOI: 10.1113/Jphysiol.1995.Sp020742  0.388
Show low-probability matches.